EUCROF e-News

January 2017

 

Dear Members, Associate Members and All,

 

Together with the EUCROF Board, I am very happy to introduce our first EUCROF e-News newsletter produced by the new Executive Board. The newsletter will allow us to share important information, news, events and celebrate successes. The newsletter is ours and every one of you is invited to contribute. Please use it as your forum for communication.

 

In November 2016, a new Board was elected (see link below). I am excited about being elected President of EUCROF and look forward to working with the board and all Members and Associate Members to further the Federation. EUCROF is already a key stakeholder for authorities in contributing to the development of better medicines for patients through CRO knowledge and expertise. The success of EUCROF is, first of all, the success of its Members and Associate Members, and the great example of the power of cooperation they demonstrate in their everyday commitment to its achievements. I look forward to ensuring its continued success and further growth.

 

In particular, I anticipate expanding EUCROF’s role with stakeholders and its participation geographically, as well as advancing the role and knowledge of CROs, as they are increasingly looked to by sponsors to improve and advance clinical trials. I believe further collaboration is important, and would like to see EUCROF become a key partner for pharmaceutical associations and authorities, contribute to the set-up of European initiatives such as the Pan European Paediatric Network funded by IMI2.  I look forward to greater involvement with patient organizations, with patients becoming more involved in clinical research and increasingly being consulted by authorities such as the EMA and pharma companies.

 

Additionally, I anticipate capitalizing on EUCROF’s willingness to expand in the larger EU geographical territory and neighbourhood, an expansion that has been formally endorsed by the approval of the new bylaws, as well as expanding to other non-EU countries and developing increased relationship with equivalent or sister organizations. First steps in that direction have already been taken, with Turkey, Ukraine and Israel having joined EUCROF. This is a logical step as drug development is increasingly a global initiative. I also aim at increasing awareness of EUCROF overall and of its robust knowledge, training systems and resources, some of which are now open to individuals outside of its membership, on a worldwide dimension.

 

I look forward to working with all of you. I wish you a happy reading.

 

Martine Dehlinger-Kremer

 

 

EUCROF NEWS AND EVENTS 

General Assembly in Munich on 28 to 30 November 2016 Election of New Executive Board.

[read more]

EUCROF has now 10 active Working Groups which span various aspects of Clinical Research. 

[read more]

Webinars planned for 2017.

[read more]

IMI2 Initiative - Pan-European Paediatric Network - Important update: The work is starting

[read more]

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and Subsequent Renovation of ICH E6

[read more]

Meeting at EMA on 28 November 2016 to discuss the EU Clinical Trial Regulation

[read more]

UAT4 of the EU CT Portal and Database completed by over 50 EUCROF testers

[read more]

EUCROF’S Vice-President presented at member’s annual conferences in UK (CCRA) and France (AFCRO) 

[read more]

 

     
FORTHCOMING EVENTS

UAT5 of the EU CT portal and database will take place in Q1 2017. Join the EUCROF team of testers! 

[read more]

EMA Stakeholder meeting on 14 March 2017 to discuss EU CT regulation implementation

[read more]

FIH Guideline Workshop – EUCROF invited to attend

[read more]

EFGCP Annual Conference 2017 on 21 & 22 February

[read more]

EUFEMED Conference in London, May 2017

[read more]